Terbutaline-induced desensitization of human cardiac β2-adrenoceptor- mediated positive inotropic effects: Attenuation by ketotifen

Cardiovascular Research

Volumn 40, Issue 1, 1998, Pages 211-222

  Poller, Ulrike ^a   Fuchs, Birgit ^a   Gorf, Antje ^a   Jakubetz, Jens ^a   Radke, Joachim ^a   Pönicke, Klaus ^a   Brodde, Otto Erich ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Desensitization; Human cardiac 1 adrenoceptors; Human cardiac 2 adrenoceptors; Ketotifen; Positive inotropic effect; Terbutaline

Indexed keywords

ALEUDRINA; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; KETOTIFEN; KETOTIFEN FUMARATE; TERBUTALINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFECT; HEART FAILURE; HEART HEMODYNAMICS; HEART RATE; HUMAN; INOTROPISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR DOWN REGULATION; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-AGONISTS; ADULT; BLOOD PRESSURE; CROSS-OVER STUDIES; HEART; HEART RATE; HISTAMINE H1 ANTAGONISTS; HUMANS; ISOPROTERENOL; KETOTIFEN; MALE; RECEPTORS, ADRENERGIC, BETA-2; SINGLE-BLIND METHOD; STIMULATION, CHEMICAL; TERBUTALINE;

EID: 0032189920     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00101-1     Document Type: Article

References (35)

1. [1] Hausdorff WP, Caron MG, Lefkowitz RJ. Turning off the signal: desensitization of β-adrenergic receptor function. FASEB J 1990;4:2881-2889.
2. [2] Lohse MJ. Molecular mechanisms of membrane receptor desensitization. Biochim Biophys Acta 1993;1179:171-188.
3. [3] Nelson HS. Adrenergic therapy of bronchial asthma. J Allergy Clin Immunol 1986;77:771-785.
4. [4] Snavely MD, Mahan LC, O'Connor DT, Insel PA. Selective down regulation of adrenergic receptor subtypes in rats with pheochromocytoma. Endocrinology 1983; 113:354-361.
5. [5] Tsujimoto G, Manger WM, Hoffman BB. Desensitization of beta-adrenergic receptors by pheochromocytoma. Endocrinology 1984;114:1272-1278.
6. [6] Bristow MR. Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol 1993;22(4):61A-71A.
7. [7] Brodde O-E, Michel MC, Zerkowski H-R. Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure. Cardiovasc Res 1995;30:570-584.
8. 2-adrenoceptors in the human heart: properties, function and alterations in chronic heart failure. Pharmacol Rev 1991;43:203-242.
9. [9] Bristow MR, Sandoval AB, Gilbert EM, et al. Myocardial α-and β-adrenoceptors in heart failure: is cardiac-derived norepinephrine the regulatory signal?. Eur Heart J 1988;9(H):35-40.
10. 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur Heart J 1989;10(B):29-37.
11. [11] Schäfers RF, Poller U, Pönicke K, et al. Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine. Naunyn-Schmiedeberg's Arch Pharmacol 1997;355:239-249.
12. [12] Muntz KH, Zhao M, Miller JC. Downregulation of myocardial β-adrenergic receptors. Receptor subtype selectivity . Circ Res 1994;74:369-375.
13. 1-adrenergic stimulation in vitro. J Cardiovasc Pharmacol 1995;25:134-141.
14. 2-agonist in humans. Circulation 1989;79:107-115.
15. 1-adrenoceptor antagonist treatment. J Am Coll Cardiol 1994;23:1224-1233.
16. 2-adrenoceptors. Accelerated restoration of β-adrenoceptor responsiveness by prednisolone and ketotifen. J Clin Invest 1985;76:1096-1101.
17. 2-adrenoceptor in vivo function in humans: attenuation by ketotifen. J Cardiovasc Pharmacol 1992;20:434-439.
18. [18] Belz GG. Systolic time intervals: a method to assess cardiovascular drug effects in humans. Eur J Clin Invest 1995;25:35-41.
19. [19] Daul A, Hermes U, Schäfers RF, et al. The β-adrenoceptor subtypes mediating adrenaline-and dobutamine-induced blood pressure and heart rate changes in healthy volunteers. J Clin Pharmacol Ther 1995;33:140-148.
20. [20] McDevitt DG. In vivo studies on the function of cardiac β-adrenoceptors in man. Eur Heart J 1989;10(B):22-28.
21. [21] Wellstein A, Belz GG, Palm D. Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots. J Pharmacol Exp Ther 1988;246:328-337.
22. [22] Strauss MH, Reeves RA, Smith DL, Leenen FHH. The role of cardiac beta-1 receptors in the hemodynamic response to a beta-2 agonist. Clin Pharmacol Ther 1986;40:108-115.
23. 2-adrenergic receptor stimulation. J Am Coll Cardiol 1997;29(1):41A.
24. 2-adrenoceptors in human atria. Med Sci Res 1987;15:1463-1465.
25. 2-Adrenergic receptor and angiotensin II receptor modulation of sympathetic neurotransmission in human atria. Circ Res 1994;74:434-440.
26. 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol. Circulation 1990;81:914-921.
27. [27] Stein M, Deegan R, Wood AJ. Long-term exposure to beta 2-receptor agonist specifically desensitizes beta-receptor-mediated venodilation. Clin Pharmacol Ther 1993;54:187-193.
28. [28] Bretz U, Martin U, Mazzoni L, Ney UM. β-Adrenergic tachyphylaxis in the rat and its reversal and prevention by ketotifen. Eur J Pharmacol 1983;86:321-328.
29. [29] Reinhardt D, Ludwig J, Braun D, Kusenbach G, Griese M. Effects of the antiallergic drug ketotifen on bronchial resistance and β-adrenoceptor density of lymphocytes in children with exercise-induced asthma. Dev Pharmacol Ther 1988;11:180-188.
30. [30] Pauwels R, Van der Straeten M. The effect of ketotifen on bronchial beta-adrenergic tachyphylaxis in normal human volunteers. J Allergy Clin Immunol 1988;81:674-680.
31. 2-bronchodilators. Eur J Clin Pharmacol 1988;34:145-150.
32. 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced β-adrenoceptor responses in man. Br J Clin Pharmacol 1985;19:619-630.
33. 1-antagonism essential for the antihypertensive action of β-blockers?. Hypertension 1987;9:198-203.
34. 2-adrenoceptor-mediated effects in humans. Am J Physiol 1988;254:H199-H206.
35. [35] Motomura S, Zerkowski H-R, Daul A, Brodde O-E. On the physiologic role of beta-2 adrenoceptors in the human heart: in vitro and in vivo studies. Am Heart J 1990;119:608-619.